[Abstract] Aim: To derive a new clinical score to improve the prediction of those at risk of poor International Normalized Ratio control among patients with atrial fibrillation taking vitamin K antagonists. Materials & methods: The score was calculated using PAULA database and validated in the FANTASIIA population. Results: The DAFNE score (cardiovascular Disease, concomitant treatment with Amiodarone, Food/dietary transgression and taking ≥7 pills daily, fEemale sex) score was related to a higher probability of poor International Normalized Ratio control. C-indexes were 0.611 and 0.576 (De Long test, p = 0.007) for the DAFNE and SAMe-TT2R2 scores, respectively. Conclusion: The DAFNE score is a new clinical score which may potentially help ...
Aims: Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recomm...
BACKGROUND: Oral anticoagulant therapy is central to the prevention thromboembolic events in atrial...
Background: The SAMe-TT2R2 (sex female, age, medical history, treatment, tobacco use, race) score wa...
Background: The time in therapeutic range (TTR) of patients with venous thromboembolism (VTE) treate...
<p><b>Objective</b>: To assess the major clinical factors affecting the quality of anticoagulation a...
The efficacy and safety of oral anticoagulation (OAC) using the vitamin K antagonists (VKA) are clos...
[Abstract] Background. Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature a...
AimsVitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend a...
AIMS: Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend...
The TIMI-AF score predicts poor outcomes in patients with atrial fibrillation (AF) and guides select...
BACKGROUND: To date, there has been no systematic examination of the relationship between internatio...
Background: Time in the therapeutic range (TTR) is associated with the effectiveness and safety of v...
Abstract Background: The SAMe-TT2R2 score was introduced to identify atrial fibrillation patients w...
Coagulation status with vitamin K antagonists (VKAs) needs to be monitored carefully to ensure maxim...
Oral anticoagulation therapy is essential in patients with atrial fibrillation and clinicians need g...
Aims: Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recomm...
BACKGROUND: Oral anticoagulant therapy is central to the prevention thromboembolic events in atrial...
Background: The SAMe-TT2R2 (sex female, age, medical history, treatment, tobacco use, race) score wa...
Background: The time in therapeutic range (TTR) of patients with venous thromboembolism (VTE) treate...
<p><b>Objective</b>: To assess the major clinical factors affecting the quality of anticoagulation a...
The efficacy and safety of oral anticoagulation (OAC) using the vitamin K antagonists (VKA) are clos...
[Abstract] Background. Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature a...
AimsVitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend a...
AIMS: Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend...
The TIMI-AF score predicts poor outcomes in patients with atrial fibrillation (AF) and guides select...
BACKGROUND: To date, there has been no systematic examination of the relationship between internatio...
Background: Time in the therapeutic range (TTR) is associated with the effectiveness and safety of v...
Abstract Background: The SAMe-TT2R2 score was introduced to identify atrial fibrillation patients w...
Coagulation status with vitamin K antagonists (VKAs) needs to be monitored carefully to ensure maxim...
Oral anticoagulation therapy is essential in patients with atrial fibrillation and clinicians need g...
Aims: Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recomm...
BACKGROUND: Oral anticoagulant therapy is central to the prevention thromboembolic events in atrial...
Background: The SAMe-TT2R2 (sex female, age, medical history, treatment, tobacco use, race) score wa...